Clinical Trial Update: Prospective Randomized Evaluation Of Celecoxib Integrated Safety Vs Ibuprofen Or Naproxen [Phase 4]

View source ↗

Summary

A Phase 4 randomized trial comparing the safety of celecoxib integration versus ibuprofen or naproxen in arthritis, with completed results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Arthritis
• Rheumatoid Arthritis

Drugs mentioned

• Celecoxib (Celecoxib)
• Ibuprofen (IBUPROFEN)
• Naproxen (Naproxen)

Snippet

Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | Conditions: Arthritis, Rheumatoid | Phase 4 | Status: COMPLETED | Results posted: 2017-05-01